Search results
Results from the WOW.Com Content Network
In 2013, CVS Caremark announced the acquisition of Coram LLC, a drug infusion business, for $2.1 billion. [15] In 2014, the corporate name for CVS Caremark became CVS Health, with CVS Caremark becoming a subsidiary. [16]
CVS Caremark provides comprehensive prescription benefit management services including mail order pharmacy services, specialty pharmacy and infusion services, plan design and administration, formulary management and claims processing. The company's clients are primarily employers, insurance companies, unions, government employee groups, health ...
MinuteClinic is a division of CVS Health (NYSE: CVS) that provides retail clinic services. [2] MinuteClinic was initially started as QuickMedx [3] by Dr. Douglas Smith and his patient Rick Krieger, along with Stephen Pontius in Minneapolis, Minnesota. MinuteClinic has more than 1,100 locations in 33 states and the District of Columbia.
CVS Health's Caremark, Cigna's Express Scripts and UnitedHealth Group's Optum control the majority of the U.S. pharmacy benefit market, with their parent companies also operating health insurance ...
Earlier this month, CVS Caremark (NYS: CVS) posted flat second-quarter profits as the drug retailer benefited from increased revenue from its drug management business. Here's a look back at what ...
Shares of CVS Caremark (NYS: CVS) galloped to a 52-week high on Wednesday. Let's take a look at how the company got there and whether clear skies remain in the forecast. How it got hereCVS ...
Since Optum's founding in 2011, the company has acquired various healthcare technology services to build out its pharmacy benefit manager and care services offerings. April 2011: UnitedHealth Group announces Optum master brand, bringing together pharmacy services, data & analytics tools, and care delivery services under one roof.
On November 7, 2007, Mac Crawford stepped down as chairman of the board for CVS Caremark. He was replaced by president and CEO of CVS Caremark, Tom Ryan. [30] On August 12, 2008, CVS Pharmacy announced that it would acquire Longs Drugs for $2.9 billion. Walgreens made a counteroffer but dropped it. The deal closed October 30, 2008.